EP Patent

EP2786997A1 — Peripheral opioid receptor antagonists and uses thereof

Assigned to Wyeth LLC · Expires 2014-10-08 · 12y expired

What this patent protects

The present invention provides a packaged composition comprising a liquid composition comprising a compound of formula III: wherein A - is a suitable anion; wherein the packaged composition is a syringe, a vial, a sachet or an ampoule; wherein the packaged composition …

USPTO Abstract

The present invention provides a packaged composition comprising a liquid composition comprising a compound of formula III: wherein A - is a suitable anion; wherein the packaged composition is a syringe, a vial, a sachet or an ampoule; wherein the packaged composition is substantially free of tungsten; optionally, wherein the compound of formula III is a compound of formula III-1 ;

Drugs covered by this patent

Patent Metadata

Patent number
EP2786997A1
Jurisdiction
EP
Classification
—
Expires
2014-10-08
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.